Trial Profile
Phase I trial of GLG-801 in patients with autosomal recessive polycystic kidney disease
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 04 Mar 2016
Price :
$35
*
At a glance
- Drugs GLG 801 (Primary)
- Indications Autosomal recessive polycystic kidney disease
- Focus Adverse reactions
- Sponsors GLG Pharma
- 04 Mar 2016 New trial record